QIM
AXSM icon

Quantitative Investment Management’s Axsome Therapeutics AXSM Stock Holding History

Quantitative Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,040
Closed -$344K – 368
2026
Q1 		$344K Sell
2,040
-484
-19% -$83.6K 0.04% 332
2025
Q4 		$460K Buy
2,524
+429
+20% +$59.9K 0.04% 322
2025
Q3 		$254K Buy
+2,095
New +$236K 0.04% 299
2025
Q2 		– Sell
-5,259
Closed -$613K – 319
2025
Q1 		$613K Buy
+5,259
New +$599K 0.06% 236
2024
Q4 		– Sell
-8,231
Closed -$739K – 327
2024
Q3 		$739K Sell
8,231
-3,568
-30% -$311K 0.07% 196
2024
Q2 		$949K Buy
+11,799
New +$874K 0.1% 164
2024
Q1 		– Sell
-10,138
Closed -$806K – 248
2023
Q4 		$806K Buy
+10,138
New +$678K 0.05% 264
2023
Q3 		– Sell
-15,300
Closed -$1.1M – 181
2023
Q2 		$1.1M Buy
+15,300
New +$1.13M 0.1% 171

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quantitative Investment Management's AXSM Position: Q2 2026 in Review

Quantitative Investment Management sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 2,040 shares — an estimated $344K sold.

Quantitative Investment Management first reported a position in AXSM in Q2 2023 and held it in 8 quarters. The position peaked at $1.1M in Q2 2023. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Quantitative Investment Management reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Quantitative Investment Management sold 2,040 Axsome Therapeutics shares in Q2 2026, an estimated $344K.
  • Quantitative Investment Management first reported a position in Axsome Therapeutics in Q2 2023 and held it in 8 quarters.
  • Quantitative Investment Management's Axsome Therapeutics position peaked at $1.1M in Q2 2023.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.